Related Experiment Videos

CD164--a novel sialomucin on CD34+ cells

S M Watt1, J Y Chan

  • 1The MRC Molecular Haematology Unit, Institute of Molecular Medicine, The John Radcliffe Hospital, Oxford, UK. Swatt@worf.molbiol.ox.ac.uk

Leukemia & Lymphoma
|March 18, 2000
PubMed

Hematopoiesis in adult bone marrow is a tightly regulated process involving interactions between cytokine and adhesion receptors on hematopoietic progenitor cells and their cognate ligands in the immediate microenvironment. These interactions control hematopoietic stem cell self-renewal, quiescence, commitment and migration. Recently, sialomucins have assumed some importance in hematopoiesis, with six of these receptors, CD34, PSGL-1, CD43, PCLP, CD45RA and CD164, having been identified on primitive hematopoietic precursor cells and/or their associated stromal/endothelial elements. This article reviews the cloning, expression and function of the recently identified sialomucin, CD164, which is highly expressed by primitive hematopoietic progenitor cells. The CD164 receptor is implicated in mediating or regulating hematopoietic precursor cell adhesion to stroma, and may serve as a potent negative regulator of hematopoietic progenitor cell proliferation.

Related Concept Videos